The purpose of the research was to investigate the mechanism of GEN playing a role in NAFLD‐induced oxidative stress and inflammation, therefore to provide a theoretical basis for the development of new potential therapy on NAFLD. This evidence concerns the gene GEN1 and metabolic dysfunction-associated steatotic liver disease.